Top Biotechnology & Medical Research stocks in North America

Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.

Name	Market Cap	Price to Earnings TTM	Dividend Yield % TTM
SLRNAcelyrin	$227.15m	n/a	n/a
MACKMerrimack Pharmaceuticals	$223.75m	n/a	n/a
KROSKeros Therapeutics	$222.81m	4.76	n/a
ALECAlector	$220.73m	n/a	n/a
ELDNEledon Pharmaceuticals	$220.28m	n/a	n/a
CRGXCARGO Therapeutics	$219.57m	n/a	n/a
CAMPCAMP4 Therapeutics	$218.06m	n/a	n/a
VYGRVoyager Therapeutics	$216.84m	n/a	n/a
HUMAHumacyte	$214.23m	n/a	n/a
SPPISpectrum Pharmaceuticals	$211.40m	n/a	n/a
ELTXElicio Therapeutics	$203.40m	n/a	n/a
ARCTArcturus Therapeutics Holdings	$202.09m	n/a	n/a
PREPrenetics Global	$201.37m	n/a	n/a
ABOSAcumen Pharmaceuticals	$200.50m	n/a	n/a
GALTGalectin Therapeutics	$199.87m	n/a	n/a
CGENCompugen	$196.67m	n/a	n/a
EDITEditas Medicine	$195.24m	n/a	n/a
PRQRProQR Therapeutics NV	$191.73m	n/a	n/a
TNYATenaya Therapeutics	$189.81m	n/a	n/a
QSIQuantum-Si	$186.47m	n/a	n/a